SCHEMBL1506742

SCHEMBL1506742

CCCCCC(O)CCC(O)C(O)CCCCC/C=C/C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.52
FFAR4 Q5NUL3 2/20 0.52
PTPN1 P18031 1/20 0.49
GPR84 Q9NQS5 4/20 0.46
FAAH O00519 2/20 0.46
PPARG P37231 2/20 0.45
GPR132 Q9UNW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506724 1.00 FFAR1 (0.52) FFAR1FFAR4PTPN1GPR84FAAH
SCHEMBL1506743 1.00 FFAR1 (0.52) FFAR1FFAR4PTPN1GPR84FAAH
SCHEMBL1506722 1.00 FFAR1 (0.52) FFAR1FFAR4PTPN1GPR84FAAH
SCHEMBL29033645 0.94 FFAR1 (0.57) FFAR1FFAR4PTPN1GPR84FAAH
SCHEMBL31197061 0.93 FFAR1 (0.43) FFAR1FFAR4PTPN1FAAHPPARG
SCHEMBL25332133 0.92 PTPN1 (0.55) FFAR1FFAR4PTPN1PPARGGPR132
SCHEMBL1129947 0.92 FFAR1 (0.59) FFAR1FFAR4PTPN1GPR84FAAH
SCHEMBL2258628 0.92 FFAR1 (0.59) FFAR1FFAR4PTPN1GPR84FAAH
SCHEMBL8335201 0.92 PTPN1 (0.55) FFAR1FFAR4PTPN1PPARGGPR132
SCHEMBL2901186 0.92 FFAR1 (0.59) FFAR1FFAR4PTPN1GPR84FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119198976-A Method for constructing model for evaluating daily ration net energy level of black pig based on metabonomics 中国农业大学三亚研究院 2024-12-27 CN claimed
US-20190078042-A1 BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE CARLSBERG A/S (DK) 2019-03-14 US claimed
US-20150218498-A1 BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE CARLSBERG A/S (DK) 2015-08-06 US claimed
JP-4805249-B2 2011-11-02 JP claimed
US-20110195151-A1 BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE CARLSBERG A/S (DK) 2011-08-11 US claimed
EP-2290089-A2 Barley for production of flavor-stable beverage Carlsberg A/S (DK) 2011-03-02 EP claimed
US-7838053-B2 Barley for production of flavor-stable beverage CARLSBERG A/S (DK) 2010-11-23 US claimed
US-20090029000-A1 Barley for Production of Flavor-Stable Beverage CARLSBERG A/S (DK) 2009-01-29 US claimed
EP-1727905-A2 BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE Carlsberg A/S (DK) 2006-12-06 EP claimed
WO-2005087934-A2 BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE CARLSBERG A/S (DK) 2005-09-22 WO claimed
US-20050204437-A1 Barley for production of flavor-stable beverage CARLSBERG A/S (DK) 2005-09-15 US claimed
US-12479812-B2 Fatty acid derivatives and their use THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2025-11-25 US disclosed
CN-119198976-A Method for constructing model for evaluating daily ration net energy level of black pig based on metabonomics 中国农业大学三亚研究院 2024-12-27 CN disclosed
EP-4468884-A1 LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT Amarin Pharmaceuticals Ireland Limited (IE) 2024-12-04 EP disclosed
WO-2023146984-A1 LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) 2023-08-03 WO disclosed
US-20090029000-A1 Barley for Production of Flavor-Stable Beverage CARLSBERG A/S (DK) 2009-01-29 US disclosed
US-7420105-B2 Barley for production of flavor-stable beverage CARLSBERG A/S (DK) 2008-09-02 US disclosed
EP-1727905-A2 BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE Carlsberg A/S (DK) 2006-12-06 EP disclosed
WO-2005087934-A2 BARLEY FOR PRODUCTION OF FLAVOR-STABLE BEVERAGE CARLSBERG A/S (DK) 2005-09-22 WO disclosed
US-20050204437-A1 Barley for production of flavor-stable beverage CARLSBERG A/S (DK) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12479812-B2 Fatty acid derivatives and their use FFAR3, FFAR1, FFAR2 FFAR1 2/4885FFAR4 4/4885PTPN1 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.